Adjuvant Zoledronic Acid in 'High Risk' Giant Cell Tumour of Bone (GCT) - A Randomized Phase II Study.
Phase of Trial: Phase II
Latest Information Update: 11 May 2015
At a glance
- Drugs Zoledronic acid (Primary) ; Calcium/colecalciferol
- Indications Bone cancer; Giant cell tumours
- Focus Therapeutic Use
- Acronyms HR-GCT
- 08 Jan 2013 New source identified and integrated: European Clinical Trials.gov record.
- 16 Apr 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 06 May 2009 New trial record